The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A global phase III multicenter, randomized, double-arm, open label trial of ASP-1929 photoimmunotherapy versus physician’s choice standard of care for the treatment of patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).
 
Merrill A. Biel
Employment - Rakuten Aspyrian
Leadership - Rakuten Aspyrian
Stock and Other Ownership Interests - Rakuten Aspyrian
Research Funding - Rakuten Aspyrian
 
Ann M. Gillenwater
Consulting or Advisory Role - Masimo; Novartis; Sanofi
Research Funding - Rakuten Aspyrian (Inst)
Travel, Accommodations, Expenses - Rakuten Aspyrian
 
David M. Cognetti
No Relationships to Disclose
 
Jennifer Maria Johnson
Consulting or Advisory Role - Foundation Medicine
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck
 
Athanassios Argiris
Consulting or Advisory Role - Aspyrian Therapeutics; Bristol-Myers Squibb; Debiopharm Group; Merck Serono; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono
Research Funding - Bristol-Myers Squibb; Genentech/Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono
 
Makoto Tahara
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck Serono; MSD; Ono Pharmaceutical
Consulting or Advisory Role - Amgen; Aspyrian Therapeutics; Bristol-Myers Squibb; Celgene; MSD; Ono Pharmaceutical; Pfizer
Research Funding - Aspyrian Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Loxo (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)